A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease
- 1 April 1991
- journal article
- Published by Elsevier in Brain Research
- Vol. 547 (1), 155-158
- https://doi.org/10.1016/0006-8993(91)90588-m
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Characterization of the cognitive effects of combined muscarinic and nicotinic blockadeBehavioral and Neural Biology, 1990
- ‘FRONTAL’ COGNITIVE FUNCTION IN PATIENTS WITH PARKINSON'S DISEASE ‘ON’AND ‘OFF’ LEVODOPABrain, 1988
- Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brainsNeuroscience Letters, 1988
- Cholinergic‐dependent cognitive deficits in Parkinson's diseaseAnnals of Neurology, 1987
- Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Alzheimer's disease: neuropathological correlates of cognitive and motor disordersActa Neurologica Scandinavica, 1987
- Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brainsNeuroscience Letters, 1986
- FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASEBrain, 1986
- Biochemical Characterization of the Nicotinic Cholinergic Receptors in Human Brain: Binding of (—)‐[3H]NicotineJournal of Neurochemistry, 1985
- Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1985